24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial
Tóm tắt
Từ khóa
Tài liệu tham khảo
Aisen, 2011, Report of the task force on designing clinical trials in early (predementia) AD, Neurology, 76, 280, 10.1212/WNL.0b013e318207b1b9
Dubois, 2007, Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria, Lancet Neurol, 6, 734, 10.1016/S1474-4422(07)70178-3
Dubois, 2014, Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria, Lancet Neurol, 13, 614, 10.1016/S1474-4422(14)70090-0
Albert, 2011, The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimers Dement, 7, 270, 10.1016/j.jalz.2011.03.008
Ngandu, 2015, A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial, Lancet, 385, 2255, 10.1016/S0140-6736(15)60461-5
Andrieu, 2017, Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial, Lancet Neurol, 16, 377, 10.1016/S1474-4422(17)30040-6
Scarmeas, 2009, Mediterranean diet and mild cognitive impairment, Arch Neurol, 66, 216
Smith, 2010, Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial, PLoS One, 5, e12244, 10.1371/journal.pone.0012244
van Wijk, 2014, Targeting synaptic dysfunction in Alzheimer's disease by administering a specific nutrient combination, J Alzheimers Dis, 38, 459, 10.3233/JAD-130998
de Wilde, 2003, Dietary fatty acids alter blood pressure, behavior and brain membrane composition of hypertensive rats, Brain Res, 988, 9, 10.1016/S0006-8993(03)03320-1
Wurtman, 2006, Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally, Brain Res, 1088, 83, 10.1016/j.brainres.2006.03.019
de Wilde, 2011, Neuroprotective effects of a specific multi-nutrient intervention against Abeta42-induced toxicity in rats, J Alzheimers Dis, 27, 327, 10.3233/JAD-2011-110635
Savelkoul, 2012, A specific multi-nutrient formulation enhances M1 muscarinic acetylcholine receptor responses in vitro, J Neurochem, 120, 631, 10.1111/j.1471-4159.2011.07616.x
Broersen, 2013, A specific multi-nutrient diet reduces alzheimer-like pathology in young adult AbetaPPswe/PS1dE9 mice, J Alzheimers Dis, 33, 177, 10.3233/JAD-2012-112039
Koivisto, 2014, Special lipid-based diets alleviate cognitive deficits in the APPswe/PS1dE9 transgenic mouse model of Alzheimer's disease independent of brain amyloid deposition, J Nutr Biochem, 25, 157, 10.1016/j.jnutbio.2013.09.015
Zerbi, 2014, Multinutrient diets improve cerebral perfusion and neuroprotection in a murine model of Alzheimer's disease, Neurobiol Aging, 35, 600, 10.1016/j.neurobiolaging.2013.09.038
Holguin, 2008, Dietary uridine enhances the improvement in learning and memory produced by administering DHA to gerbils, FASEB J, 22, 3938, 10.1096/fj.08-112425
Jansen, 2013, Effects of specific multi-nutrient enriched diets on cerebral metabolism, cognition and neuropathology in AbetaPPswe-PS1dE9 mice, PLoS One, 8, e75393, 10.1371/journal.pone.0075393
Cansev, 2015, A specific multi-nutrient enriched diet enhances hippocampal cholinergic transmission in aged rats, Neurobiol Aging, 36, 344, 10.1016/j.neurobiolaging.2014.07.021
Janickova, 2015, Lipid-based diets improve muscarinic neurotransmission in the hippocampus of transgenic APPswe/PS1dE9 Mice, Curr Alzheimer Res, 12, 923, 10.2174/1567205012666151027130350
de Wilde, 2017, Lower brain and blood nutrient status in Alzheimer's disease: results from meta-analyses, Alzheimers Dement, 3, 416, 10.1016/j.trci.2017.06.002
Scheltens, 2010, Efficacy of a medical food in mild Alzheimer's disease: a randomized, controlled trial, Alzheimers Dement, 6, 1, 10.1016/j.jalz.2009.10.003
Scheltens, 2012, Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial, J Alzheimers Dis, 31, 225, 10.3233/JAD-2012-121189
de Waal, 2014, The effect of Souvenaid on functional brain network organisation in patients with mild Alzheimer's disease: a randomised controlled study, PLoS One, 9, e86558, 10.1371/journal.pone.0086558
Shah, 2013, The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer's disease, Alzheimers Res Ther, 5, 59, 10.1186/alzrt224
Olde Rikkert, 2015, Tolerability and safety of Souvenaid in patients with mild Alzheimer's disease: results of multi-center, 24-week, open-label extension study, J Alzheimers Dis, 44, 471, 10.3233/JAD-141305
Cummings, 2017, Effect size analyses of Souvenaid in patients with Alzheimer's disease, J Alzheimers Dis, 55, 1131, 10.3233/JAD-160745
Harrison, 2007, A neuropsychological test battery for use in Alzheimer disease clinical trials, Arch Neurol, 64, 1323, 10.1001/archneur.64.9.1323
Hamel, 2015, The trajectory of cognitive decline in the pre-dementia phase in memory clinic visitors: findings from the 4C-MCI study, Psychol Med, 45, 1509, 10.1017/S0033291714002645
Ellis, 2014, Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL), Int Psychogeriatr, 26, 543, 10.1017/S1041610213001956
Kamphuis, 2011, Efficacy of a medical food on cognition in Alzheimer's disease: results from secondary analyses of a randomized, controlled trial, J Nutr Health Aging, 15, 720, 10.1007/s12603-011-0105-6
Vellas, 2015, Endpoints for pre-dementia AD trials: a report from the EU/US/CTAD Task Force, J Prev Alzheimers Dis, 2, 128
Vellas, 2008, Endpoints for trials in Alzheimer's disease: a European task force consensus, Lancet Neurol, 7, 436, 10.1016/S1474-4422(08)70087-5
Vos, 2015, Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage, Brain, 138, 1327, 10.1093/brain/awv029